Clinical Trials List
2023-07-01 - 2027-11-30
Phase II
Not yet recruiting8
Recruiting2
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Pai-Chien Chou Division of General Internal Medicine
- Chi-Li Chung Division of General Internal Medicine
- Shang-Fu Hsu Division of General Internal Medicine
- Kai-Ling Lee Division of General Internal Medicine
- 蕭世欣醫師 Division of General Internal Medicine
- 陳美娟醫師 Division of General Internal Medicine
- 周俊良醫師 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- James Chih-Hsin Yang Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of General Internal Medicine
- 林昭文 Division of Ophthalmology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- Jih-Hsiang Lee Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- 廖斌志 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- 徐偉勛 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hsu-ching Huang Division of Thoracic Medicine
- Heng-Sheng Chao Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YEN-HSIANG HUANG Division of General Internal Medicine
- 李柏昕醫師 Division of General Internal Medicine
- JENG-SEN TSENG Division of General Internal Medicine
- KUO-HSUAN HSU Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 陳昭勳 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 林建良醫師 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 林建良醫師 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 廖偉志 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 趙東瀛 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 陳彥豪 Division of Thoracic Medicine
- 陳怡豪 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Thoracic Medicine
- 張育平醫師 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 張育平醫師 Division of Thoracic Medicine
- 林理涵 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 陳友木 Division of Thoracic Medicine
- 李易濰 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
80 participants
